Melanoma (Skin)
Oncology·MeSH: Melanoma
Prevalence
75.0 / 100K
Incidence
23.0 / 100K/yr
8 drugs in development·2 companies·7 clinical trials
Drug Pipeline by Phase
Phase 3(2)
Early Phase 1(1)
| Drug | Company |
|---|---|
| cd137 | GH Research PLC (GHRS) |
Phase 1/Phase 2(4)
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| fludarabine | GH Research PLC (GHRS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Melanoma (Skin)?
BioSniper tracks 8 drugs in development for Melanoma (Skin) across 2 companies.
How many clinical trials target Melanoma (Skin)?
There are 7 clinical trials targeting Melanoma (Skin) tracked by BioSniper.
What is the prevalence of Melanoma (Skin)?
The estimated prevalence of Melanoma (Skin) is approximately 75.0 per 100,000 population.
Deep-dive into Melanoma (Skin)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis